Rare Diseases Activities
Module 4: Managing Cystic Fibrosis-Related Complications - 1.5 Credits
0290-0000-19-147-H01-P
This module will investigate the pathophysiology, treatment, and impact of cystic fibrosis-related diabetes on patients with cystic fibrosis (CF).
1.50
Module 5: Cystic Fibrosis Communication, Counseling Tips, and the CF Treatment Horizon - 0.5 Credits
0290-0000-19-148-H01-P
This module will discuss the importance of good communication and counseling tips for patients with cystic fibrosis (CF).
0.50
Examining the Current Landscape of Idiopathic Pulmonary Fibrosis: Reducing the Health and Economic Burden of Disease
0290-0000-19-142-H01-P
This supplement will provide an overview of the most current guidelines for the diagnosis and management of IPF including the recent clinical data for the FDA-approved therapies.
2.00
Examining Best Practices for Specialty Pharmacists to Improve the Care of Patients With Amyotrophic Lateral Sclerosis (ALS)
0290-0000-19-132-H01-P
This article will explore ALS pathophysiology, clinical signs and symptoms, disease progression, FDA-approved therapies for ALS, current investigational agents, and the role of specialty pharmacists and multidisciplinary clinic platforms in the care of patients with ALS.
2.50